Related by context. All words. (Click for frequent words.) 78 Acute Myelogenous Leukemia 74 Myelodysplastic Syndrome MDS 74 metastatic malignant 74 Myelodysplastic Syndromes 74 Cutaneous T 73 Myelofibrosis 73 Glioblastoma Multiforme 72 Hormone Refractory Prostate Cancer 72 Chronic Myelogenous Leukemia 72 Chronic lymphocytic leukemia 72 Relapsed Refractory 72 Chronic Myeloid Leukemia 71 Atypical Hemolytic Uremic Syndrome 71 Idiopathic Pulmonary Fibrosis 71 Advanced Melanoma 71 Waldenstrom macroglobulinemia 71 Follicular Lymphoma 71 gastrointestinal stromal tumor 71 Mantle Cell Lymphoma 71 Advanced Renal Cell 71 atypical Hemolytic Uremic Syndrome 71 Diabetic Nephropathy 70 recurrent glioblastoma multiforme 70 Investigational Treatment 70 mycosis fungoides 70 Acute Leukemia 70 Soft Tissue Sarcoma 70 Prolongs Survival 70 Leukemias 70 Improves Outcomes 70 Acute Myelogenous Leukemia AML 70 leukemia AML 70 Eculizumab 70 B Cell Lymphoma 70 acute myeloid 70 Enzyme Replacement Therapy 70 Juvenile Idiopathic Arthritis 70 Renal Impairment 70 pulmonary hypertension PH 70 Myelodysplasia 70 Patients Receiving 70 Chronic Lymphocytic Leukemia 70 Anaplastic 70 Renal Cell Carcinoma 70 complement inhibitor eculizumab 70 Severe Sepsis 70 Malignant Melanoma 69 thalidomide Thalomid 69 Adjuvant Chemotherapy 69 T Cell Lymphoma 69 idiopathic thrombocytopenic purpura 69 Naive Patients 69 Cell Lymphoma 69 Hyperkalemia 69 Etanercept 69 Newly Diagnosed 69 Diabetic Foot Ulcer 69 Severe Asthma 69 Hepatocellular Carcinoma HCC 69 ST Elevation Myocardial 69 Diffuse Large B 69 refractory chronic lymphocytic 69 Anthracycline 69 Chronic Sinusitis 69 Ischemic 69 Cholangiocarcinoma 69 Shows Promise Against 69 Systemic Sclerosis 69 Microalbuminuria 69 Acute Myeloid Leukemia 69 Overactive Bladder 69 Sjogren Syndrome 69 Sipuleucel T 69 Adenomas 69 metastatic gastric 69 Carcinoma 68 Metastatic Melanoma 68 Lymphocytic 68 allogeneic bone marrow 68 Acute Renal Failure 68 MPGN 68 Refractory Hodgkin Lymphoma 68 Mouse Model 68 Pulmonary Arterial Hypertension 68 Thrombocytopenia 68 Chronic Pelvic Pain 68 Bevacizumab 68 Metastases 68 Predict Response 68 Progressive Multifocal Leukoencephalopathy 68 Esophagitis 68 Newly Diagnosed Multiple Myeloma 68 Epstein Barr Virus 68 Aflibercept 68 Chronic Myeloid Leukemia CML 68 Acute myeloid leukemia 68 Epratuzumab 68 Treated Patients 68 Paroxysmal Nocturnal Hemoglobinuria 68 Antitumor Activity 68 gefitinib Iressa 68 Unresectable 68 Hypotension 68 Castration Resistant Prostate Cancer 68 Treating Chronic 68 Hodgkin lymphoma HL 68 Squamous Cell Carcinoma 68 Glioblastoma Multiforme GBM 68 Prophylactic Treatment 68 Newly Diagnosed Patients 68 smoldering myeloma 68 Ventricular Tachycardia 68 Bronchiectasis 68 subependymal giant cell 68 Delayed Graft Function 68 Tyrosine Kinase Inhibitors 68 chronic granulomatous disease 68 Multiple Myeloma MM 68 Adenoma 68 malignant pleural mesothelioma 68 Thrombotic 68 Lupus Nephritis 68 Multiple Myeloma Patients 68 Myelodysplastic syndrome 67 Lymphoid 67 Pemetrexed 67 Relapsing Remitting Multiple Sclerosis 67 Treatment Resistant 67 Oral Fingolimod 67 Systemic Lupus Erythematosus 67 Stomach Cancer 67 Philadelphia Chromosome Positive 67 Hepatocellular Carcinoma 67 Degarelix 67 dual endothelin receptor antagonist 67 atypical hemolytic uremic syndrome 67 acute myelogenous 67 dasatinib Sprycel ® 67 Metastatic Colorectal Cancer 67 Tyrosine Kinase Inhibitor 67 AA Amyloidosis 67 myelodysplastic syndrome MDS 67 Long Term Efficacy 67 Septic Shock 67 Hematologic 67 Carcinoid 67 Radiofrequency Ablation RFA 67 Decitabine 67 Paroxysmal Nocturnal Hemoglobinuria PNH 67 Radioimmunotherapy 67 Chronic Myelogenous Leukemia CML 67 Solid Tumors 67 alpha1 antitrypsin deficiency 67 Relapsing Multiple Sclerosis 67 Occlusive Disease 67 Slow Progression 67 Liver Failure 67 thrombocytosis 67 Pleural Mesothelioma 67 Ribavirin causes 67 myelodysplasia 67 immune thrombocytopenic purpura 67 Improve Survival 67 Adenocarcinoma 67 Combo Therapy 67 metastatic malignant melanoma 67 Disease Modifying 67 leukemia CLL 67 Vasculitis 67 NMIBC 67 Complicated Skin 67 Thromboembolic 67 Autoimmune Disease 67 myeloid metaplasia 67 Successfully Treats 67 Well Tolerated 67 Heterozygous Familial Hypercholesterolemia 67 Meets Primary Endpoint 67 Liver Metastases 67 Reduces Mortality 67 Myeloma Patients 67 allogeneic hematopoietic stem cell 67 Chronic Kidney 67 Heart Failure Patients 67 Malignancies 67 Estrogen Receptor 67 SPRYCEL ® 67 Gastric Cancer 67 Pegylated Liposomal Doxorubicin 67 lymphocytic leukemia 67 Bladder Cancer 67 Non Hodgkin 67 ADPKD 67 Papillary 67 hemophagocytic lymphohistiocytosis 67 Bosutinib 67 SHPT 67 Previously Treated 66 mastocytosis 66 ZACTIMA TM ZD# 66 Chronic Rhinosinusitis 66 Systemic Lupus Erythematosus SLE 66 Adjunctive Therapy 66 Chronic Hepatitis C 66 Dual Antiplatelet Therapy 66 Breast Cancer Recurrence 66 psoriatic arthritis PsA 66 carcinoid tumors 66 haematologic 66 acute leukemia AML 66 Ovarian Cancer Patients 66 Critical Limb Ischemia CLI 66 Patients Treated With 66 Neovascular Age Related Macular 66 essential thrombocythemia ET 66 Phase 2b Trial 66 hypereosinophilic syndrome 66 Glioma 66 Immunosuppression 66 Autoimmune Diseases 66 Rheumatoid Arthritis Patients 66 Antiangiogenic 66 Drug Prevents 66 Idiopathic Thrombocytopenic Purpura ITP 66 Autologous Stem Cell Transplantation 66 Adjuvant Treatment 66 Renal Cancer 66 Retreatment 66 Aliskiren 66 thymoma 66 Carcinoid Syndrome 66 Chronic Lymphocytic Leukemia CLL 66 Platinol ® 66 Phase 2b Clinical Trial 66 stem cell engraftment 66 Peripheral Arterial 66 Relapsed Refractory Multiple Myeloma 66 cholangiocarcinoma 66 Enzastaurin 66 malignant ascites 66 Esophageal Cancer 66 Disease Progression 66 vWD 66 proliferative retinopathy 66 Node Positive 66 R lenalidomide 66 pancytopenia 66 ara C 66 leukoencephalopathy 66 Clinical Trial Results 66 Pemphigus 66 Allogeneic 66 Cell Lymphoma CTCL 66 adalimumab Humira 66 Androgen Deprivation Therapy 66 Hormone Receptor Positive 66 autoimmune thyroid 66 Treatment Shows Promise 66 systemic anaplastic large 66 Chemoradiation 66 efalizumab 66 Hepatotoxicity 66 Wilms Tumor 66 Tumor Growth 66 Rheumatoid 66 Acute Heart Failure 66 Diabetic Patients 66 Hyperlipidemia 66 Neovascularization 66 recurrent glioblastoma 66 systemic mastocytosis 66 Metastatic Prostate Cancer 66 Inflammatory Markers 66 stage IIIB 66 Morquio 66 transplantation HCT 66 Basal Cell 66 Malignant Glioma 66 Adjuvant Therapy 66 Survival Benefit 66 Chronic Renal Failure 66 Metastatic 66 Metastatic Renal Cell Carcinoma 66 myelodysplastic myeloproliferative diseases 66 refractory cutaneous T 66 RNAi Therapeutic 66 Interferon Beta 66 Sapacitabine 66 Cognitive Impairment 66 leukemia ALL 66 Hypertrophic 66 induce orthostatic hypotension 66 Acute Myeloid Leukaemia AML 66 Graft Versus Host 66 Intracerebral Hemorrhage 66 Tumor Necrosis Factor 66 eosinophilic pneumonia 66 Neoplasms 66 chronic eosinophilic leukemia 66 Pooled Analysis 66 cell lymphoma CTCL 66 Lennox Gastaut Syndrome 66 basiliximab 66 Fingolimod 66 carcinoid 66 Knee Osteoarthritis 66 allogeneic hematopoietic cell 65 Pancreatic 65 papillary renal cell carcinoma 65 sunitinib Sutent 65 Slows Progression 65 Phase IIa Clinical Trial 65 Bone Metastases 65 kidney urologic 65 paraganglioma 65 CYT# potent vascular disrupting 65 Cyclophosphamide 65 Tumor Response 65 GW# [003] 65 tyrosine kinase inhibitors TKIs 65 Phase 2b Study 65 Dose Ranging Study 65 PTLD 65 Epidermal Growth Factor Receptor 65 HER2 Positive Breast Cancer 65 diffuse intrinsic pontine glioma 65 Blood Cancers 65 paroxysmal nocturnal hemoglobinuria 65 Idiopathic Thrombocytopenic Purpura 65 Breast Cancer Treatment 65 Hemolysis 65 Natalizumab 65 Acute Exacerbations 65 Risk Stratification 65 See CLINICAL PHARMACOLOGY 65 myelogenous leukemia 65 Nilotinib 65 Acute Decompensated Heart Failure 65 relapsing multiple sclerosis 65 erythematosus 65 Investigational Drug 65 Hypertrophy 65 Alemtuzumab 65 chronic thromboembolic pulmonary 65 Liver Injury 65 Minimally Invasive Procedure 65 Kidney Failure 65 Combination Treatment 65 non hodgkin lymphoma 65 chronic lymphocytic 65 dasatinib Sprycel 65 erlotinib Tarceva ® 65 Liver Cancer 65 advanced hepatocellular carcinoma 65 Safinamide 65 Cognitive Deficits 65 Neoadjuvant Chemotherapy 65 Hurthle cell 65 hepatorenal syndrome 65 Myocardial Ischemia 65 dyskeratosis congenita 65 tumor lysis syndrome 65 Acute Ischemic Stroke 65 Dasatinib 65 Advanced Prostate Cancer 65 Fabry Disease 65 Mitoxantrone 65 relapsed leukemia 65 Hyperphosphatemia 65 Meningiomas 65 acute humoral rejection 65 Acute Bacterial Sinusitis ABS 65 Gaucher Disease 65 invasive aspergillosis 65 Parnate 65 Infected Patients 65 smoldering multiple myeloma 65 Intracoronary 65 recurrent sinusitis 65 Immunologic 65 Diabetic Neuropathy 65 chronic GVHD 65 Exacerbation 65 Nebulized 65 Chronic HCV 65 myocardial infarction ventricular fibrillation 65 Unstable Angina 65 Preclinical Models 65 Post Operative 65 chronic myeloid 65 Belldegrun 65 Dilated Cardiomyopathy 65 cytopenias 65 Myocarditis 65 Von Willebrand disease 65 Arrhythmogenic 65 Stem Cell Transplant 65 metastatic colorectal 65 homozygous familial hypercholesterolemia 65 PCNSL 65 Improved Survival 65 lichen planus 65 diabetes mellitus DM 65 Idiopathic Pulmonary Fibrosis IPF 65 Chronic Heart Failure 65 Azacitidine 65 Dyskinesia 65 Myelodysplastic Syndromes MDS 65 Gene Linked 65 relapsed MM 65 Ventricular Arrhythmias 65 Oesophageal 65 Chronic Bronchitis 65 ZACTIMA 65 pleural mesothelioma 65 Romiplostim 65 Ischaemic 65 HCV Protease Inhibitor 65 Juvenile Rheumatoid Arthritis 65 Novel Treatments 65 anthracyclines taxanes 65 lupus erythematosus 65 chronic rheumatic 65 Hepatic Encephalopathy 65 diabetic kidney 65 recurrent NSCLC 65 Sezary syndrome 65 CYP#A# substrate 65 myeloproliferative disorder 65 Targeted Therapy 65 Carbamazepine 65 ACE Inhibitors 65 Sprycel dasatinib 65 Intravenous immunoglobulin 65 SSc 65 Endometrial Cancer 65 Clinical Outcome 65 Toxicities 65 haematologic malignancies 65 Pegloticase 65 Immunosuppressive 65 Transcatheter 65 ANCA associated 65 transthyretin amyloidosis 65 Hematopoietic 65 metastatic neuroendocrine tumors 65 Chemotherapy Induced 65 Ischemic Stroke 65 Hemorrhagic Stroke 65 metastatic GIST 65 Drug Shows Promise 65 Chemotherapy induced 65 Xelox 65 Randomized Study 65 Improves Survival 65 Dysplasia 65 Squamous 65 Mouse Models 65 Hypercholesterolemia 65 Adjunctive 65 Diabetic Foot Ulcers 65 Antigen Specific 65 Systemic lupus erythematosus SLE 65 Temsirolimus 65 Idiopathic pulmonary fibrosis 65 Subtypes 65 Prostatic 65 Hydroxyurea 65 Treatment Naive Patients 64 Colorectal Cancer Patients 64 Anticoagulant 64 Relapsed Multiple Myeloma 64 lung fibrosis 64 myelofibrosis polycythemia vera 64 Radiofrequency Ablation 64 gastrointestinal stromal tumors GIST 64 Short Stature 64 Gleevec resistant 64 Chronic Inflammatory 64 Patients Undergoing 64 Elderly Patients 64 Genes Predict 64 Cardiac Stem Cell 64 Iron Overload 64 HDAC Inhibitor 64 idiopathic thrombocytopenic purpura ITP 64 Autoantibodies 64 thrombotic thrombocytopenic purpura 64 Lung Cancer Drug 64 torsade de pointes 64 Neuroendocrine Tumors 64 Velcade bortezomib 64 Hematological 64 Previously Untreated 64 Retinitis Pigmentosa RP 64 Immunosuppressant 64 refractory indolent non 64 Fungal Infections 64 Interstitial cystitis 64 Hepatitis C Genotype 64 Mucositis 64 Niemann Pick disease 64 Hemophilia B 64 Diagnostic Criteria 64 5 Fluorouracil 64 Bullous 64 Systemic lupus erythematosus 64 Neoadjuvant 64 colorectal carcinoma 64 Fulvestrant 64 Synovial Sarcoma 64 Venous Thromboembolism 64 Renal Function 64 TTF Therapy 64 Aurora Kinase 64 Demonstrates Sustained 64 neuroendocrine cancers 64 Cell Non Hodgkin 64 Anti Tumor 64 LHRH receptor positive 64 Nesiritide 64 unresectable tumors 64 Invasive Breast Cancer 64 Shows Efficacy 64 hypervascular tumors 64 cystic fibrosis chronic pancreatitis 64 papillary carcinoma 64 MELAS 64 Sclerosis 64 IL# PE#QQR 64 Trastuzumab 64 Ph + acute lymphoblastic 64 Fluorouracil 64 anthracycline taxane 64 Resection 64 Kidney Transplant Patients 64 deletion 5q 64 Pegylated Interferon 64 Predict Risk 64 systemic lupus erythematosus psoriasis 64 STRIDE PD 64 Primary Hypercholesterolemia 64 squamous cell lung cancer 64 Enlarged Prostate 64 Receptor Antagonists 64 Cimzia TM 64 acute mania 64 Genetic Marker 64 anaplastic astrocytoma 64 Drug Candidate 64 precancerous condition 64 Doxil ® 64 eosinophilic asthma 64 imatinib Gleevec 64 Hematopoietic Stem Cell Transplantation 64 overactive bladder syndrome 64 Advanced Colorectal Cancer 64 Sustained Efficacy 64 Lung Cancer Patients 64 Allergic Rhinitis 64 pouchitis 64 Phase 2a Trial 64 HER2 Positive 64 Angioedema 64 deep venous thromboses 64 Mitral Regurgitation 64 Waldenstrom Macroglobulinemia 64 Renal Insufficiency 64 Irinotecan 64 Thromboembolism 64 neurogenic bladder 64 Bortezomib 64 Deferiprone 64 Cardiotoxicity 64 Serious Infections 64 Cancer Patients Treated 64 Skeletal Muscle 64 colorectal liver metastases 64 Hsp# Inhibitor 64 Fibrosis 64 pancreatic adenocarcinoma 64 Cell Transplants 64 Carcinomas 64 Ozarelix 64 Hyperuricemia 64 Neuroprotection 64 Hodgkin lymphoma NHL 64 Solid Tumor 64 Metastatic breast cancer 64 Valvular Heart Disease 64 Kinase Inhibitors 64 leiomyomas 64 either acutely decompensated 64 Gene Mutation 64 Benign Prostatic Hyperplasia 64 Mg Usa 64 unresectable stage 64 bullous 64 refractory myeloma 64 MGd 64 Leber Hereditary Optic Neuropathy 64 Genes Linked 64 Zarnestra 64 PAOD 64 Antiviral Therapy 64 myeloproliferative neoplasms 64 Appears Safe 64 Sclerosing 64 achieved CCyR 64 Endothelial 64 multiforme 64 severe neutropenia 64 Fludarabine 64 Metabolic Disorder 64 Chronic Prostatitis 64 Diabetic Neuropathic Pain 64 NAGS deficiency 64 Virus Linked 64 Dendritic Cells 64 receiving immunosuppressive therapy 64 allograft rejection 64 abacavir Ziagen 64 biliary tract cancer 64 metastatic pancreatic 64 Severe Primary IGFD 64 Bisphosphonate 64 Prostate Cancer Patients 64 Ulcerative colitis 64 Hemodialysis Patients 64 Peginterferon 64 Pralatrexate 64 receptor tyrosine kinase inhibitor 64 Acute Coronary Syndromes ACS 64 Drug Combo 64 antiphospholipid syndrome 64 Breast Cancers 64 Novel Oral 64 Meta Analysis 64 Langerhans cell histiocytosis 64 erlotinib Tarceva 64 Embolization 64 mild renal insufficiency 64 Peritoneal Mesothelioma 64 Ischemia 64 hyperphenylalaninemia HPA due 64 secondary hyperparathyroidism 64 Osteomyelitis 64 Amyloid 64 Pediatric Patients 64 steroid refractory ulcerative 64 ® lenalidomide 64 Acute Myeloid Leukaemia 64 Parkinson Disease PD 64 Inflammatory Diseases 64 Amgen Neulasta R 64 transcranial Doppler ultrasound 64 Astrocytoma 64 Venous thromboembolism 64 purpura ITP 64 Primary Biliary Cirrhosis 64 Asthma COPD 64 HBeAg negative 64 dermatologic reactions 64 Wegener granulomatosis 64 severe malignant osteopetrosis 64 systemic lupus erythematosus 64 essential thrombocythemia 64 Treatment Reduces 64 Intra arterial 64 chronic idiopathic 64 pediatric acute lymphoblastic 64 severe oral mucositis 64 cutaneous T 64 relapsing remitting MS RRMS 64 terlipressin 64 Medulloblastoma 64 familial amyloidotic polyneuropathy FAP 64 galiximab 64 Prognostic Factors 64 Chronic Lung 64 Idiopathic 64 Successfully Treated 64 fibromyalgia syndrome 64 Genes Identified 64 Immunotherapeutic 64 FDA Approves Drug 64 Hepatitis C Infection 64 Cachexia 64 Critical Limb Ischemia 64 Tacrolimus 64 Vidaza azacitidine 64 methimazole 64 pemphigus vulgaris 63 Renal Anemia 63 Non Alcoholic Fatty 63 NOMID 63 Progenitor Cells 63 allogeneic stem cell 63 Antitumor activity 63 Ziprasidone 63 Advanced Solid Tumors 63 PKC# 63 Pancreas Cancer 63 hematopoietic cell 63 Postherpetic Neuralgia 63 ankylosing spondylitis AS 63 ribavirin RBV 63 TTR amyloidosis 63 hepatocellular carcinoma liver 63 mild hepatic impairment 63 Nicotine Vaccine 63 Randomized Double blind 63 TNF Blockers 63 refractory acute myeloid 63 azacytidine 63 Cardiac Resynchronization 63 ISTODAX ® 63 Malignancy 63 Eisenmenger syndrome 63 Leber Congenital Amaurosis LCA 63 myelodysplastic syndrome 63 Proteinuria 63 Single Dose 63 Catheter Ablation 63 Muscle Function 63 AA amyloidosis 63 Prednisone Against Refractory 63 Bronchopulmonary Dysplasia 63 juvenile idiopathic arthritis 63 Phase III Trial 63 Chronic Obstructive Pulmonary 63 moderate renal impairment 63 Aortic Stenosis 63 Gene Variant 63 Major Depressive Disorder 63 Localized Prostate Cancer 63 Insulin Resistance 63 invasive candidiasis 63 Glioblastoma 63 FDA Approvals 63 Hepatocellular 63 SNT-MC#/idebenone 63 Hypertriglyceridemia 63 Lamotrigine 63 Multicenter Study 63 arteriovenous malformations 63 Etiology 63 Granted Orphan Drug 63 portal vein thrombosis 63 cell acute lymphoblastic 63 Cannabinoid 63 Lenalidomide 63 acute lymphoblastic 63 Endometrial 63 Teriflunomide 63 Subgroup Analysis 63 Valvular 63 Nonalcoholic fatty liver 63 Esophageal 63 Bucindolol 63 post transplant lymphoproliferative 63 Small Intestine 63 Initiates Clinical Trial 63 Peginterferon alfa 2b 63 Peripheral Artery Disease 63 Zollinger Ellison Syndrome 63 Anticancer Drug 63 INSPIRE Trial Phase III 63 polycythemia vera essential thrombocythemia 63 Non Hodgkin Lymphoma 63 Coronary Artery Bypass Graft 63 Plaque Psoriasis 63 antibody MAb 63 Emerging Therapies 63 Peginterferon Alfa 2a 63 Deforolimus 63 Hematological Malignancies 63 Omacetaxine 63 aplastic anemia AA 63 Initiate Clinical Trial 63 Secondary Hyperparathyroidism 63 Psoriatic arthritis 63 Thymic 63 Bipolar Mania 63 cetuximab Erbitux R 63 Immune Responses 63 neoadjuvant treatment 63 thymic carcinoma 63 carcinoma mCRC 63 Sustained Reduction 63 Intravitreal 63 EVIZON TM 63 AVASTIN 63 Intravascular 63 Thyroid Cancer 63 Gastrointestinal GI 63 Therapy Evaluation 63 GRNOPC1 contains 63 Cytochrome P# 63 Resistant Hypertension 63 Alveolar 63 Primary Immunodeficiency 63 Rheumatoid Arthritis RA 63 Metastatic Pancreatic Cancer 63 sorafenib Nexavar 63 primary hyperparathyroidism 63 Paraplatin ® 63 Juvenile Idiopathic Arthritis JIA 63 erythematosus SLE 63 Pivotal Clinical Trial 63 Pulmonary Hypertension 63 included exfoliative dermatitis 63 pheochromocytoma 63 cisplatin gemcitabine 63 ductal adenocarcinoma 63 pretransplant 63 alfa 2a 63 Dupuytren Contracture 63 estramustine 63 Comorbid 63 Hepatic 63 Immunomodulatory 63 Amyotrophic lateral sclerosis ALS 63 Dacogen decitabine 63 Tolvaptan 63 Pharmacologic 63 Migraine Headache 63 allogeneic HSCT 63 Cimzia ® certolizumab pegol 63 treat chronic sinusitis 63 Non Invasive Treatment 63 TACI Ig 63 bronchial hyperresponsiveness 63 BARACLUDE ® 63 immunodeficiency disorders 63 Noxafil 63 heparin induced thrombocytopenia 63 Monotherapy 63 Orthostatic Hypotension 63 demethylating agent 63 hematopoietic cancers 63 JAK2 Inhibitor 63 recurrent glioma 63 diabetic gastroparesis 63 elevated transaminases 63 Rituxan rituximab 63 hyperplasia BPH 63 Diabetic Ulcers 63 gastrointestinal stromal tumor GIST 63 Epstein Barr Virus EBV 63 HCV Genotype 63 Certolizumab pegol 63 Transdermal Patch 63 Blood Clots 63 Asymptomatic 63 Seasonal Allergic Rhinitis 63 myeloproliferative disorders 63 histological subtype 63 Cystectomy 63 Anti Tumor Activity 63 choriocarcinoma 63 hematological malignancy 63 Infantile Spasms 63 metastatic colorectal carcinoma 63 Fanconi Anemia 63 Major Depressive Disorder MDD 63 mismatched bone marrow 63 Virologic 63 glomerulonephritis 63 Study Evaluating 63 Phase IIb Trial 63 Increased Mortality 63 optic neuropathy 63 renal failure interstitial lung 63 alefacept 63 hormone refractory metastatic prostate 63 Transplant Rejection 63 Dementia Related Psychosis 63 stage IIIb IV 63 Community Acquired Pneumonia 63 Vascular Dementia 63 Placebo Controlled Study 63 Treatable 63 INTEGRILIN R 63 HQK 63 Gleevec imatinib 63 Non Alcoholic Steatohepatitis 63 urothelial cancer 63 Muscle Wasting 63 idiopathic pulmonary fibrosis IPF 63 icatibant 63 Demonstrates Efficacy 63 Prostate Cancer Treatment 63 Vandetanib 63 metastatic bladder 63 adriamycin 63 Anticonvulsant 63 lymphoid malignancies 63 investigational pharmacologically unique 63 follicular Non Hodgkin 63 Inflammatory Disease 63 intravesical infusion therapy 63 Patients Suffering 63 Complete Remission 63 Aviptadil 63 Pivotal Trial 63 purpura 63 sunitinib Sutent ® 63 exocrine pancreatic insufficiency EPI 63 Treat Anemia 63 Limb Ischemia 63 Fondaparinux 63 Patients Treated 63 prostate cancer CRPC 63 Critically Ill Patients 63 JMML 63 Treatment Outcome 63 Accelerated Partial Breast Irradiation 63 immune thrombocytopenic purpura ITP 63 riociguat 63 Acute Lymphoblastic Leukemia 63 Rectal Cancer 63 Antipsychotic 63 Lung Injury 63 Actinic Keratosis 63 Investigational Compound 63 Squamous Cell 63 CIMZIA ™ 63 chemo immunotherapy 63 Carotid Revascularization Endarterectomy vs. 63 Arranon 63 Colorectal Adenomas 63 patientswith 63 Helicobacter pylori eradication 63 Cutaneous 63 Renal Cell Cancer 63 cisplatin chemotherapy 63 denileukin diftitox 63 Liprotamase 63 Treat Heart Failure 63 EXJADE 63 Nodular 63 Basal Cell Carcinoma 63 Sudden Cardiac Death 63 esophageal candidiasis 63 hypokalemia hypomagnesemia 63 Pancreatitis 63 targeted radiotherapeutic 63 malignant pleural effusion 63 commercialize deforolimus 63 Interferon beta 1a 63 Adjuvant therapy 63 Corneal Transplant 63 FOLFOX6 63 rFVIIa 62 gemcitabine Gemzar ® 62 Atherosclerotic 62 nicardipine 62 familial adenomatous polyposis 62 Uterine Cancer 62 palifermin 62 Hurler syndrome 62 unstable angina UA 62 imatinib Gleevec ® 62 Kinase Inhibitor 62 Hedgehog Pathway Inhibitor 62 Denufosol 62 paragangliomas 62 Stenosis 62 lymphoma leukemia 62 DOXIL 62 Host Disease GvHD 62 fructose intolerance 62 Cholesterol Lowering Drug 62 differentiated thyroid 62 nonmetastatic prostate cancer 62 Stem Cell Transplants 62 DFMO 62 Postmenopausal Osteoporosis 62 PEGINTRON TM 62 myeloproliferative diseases 62 DIPG 62 peritoneal carcinomatosis 62 vincristine doxorubicin 62 Myasthenia gravis 62 Left Ventricular 62 Efficacy Trial 62 Pulmonary hypertension 62 Combination REOLYSIN R 62 non polyposis colorectal 62 Ascites 62 Acute Coronary Syndromes 62 Antifungals 62 Retinopathy 62 angiosarcoma 62 diabetes mellitus T2DM 62 Daclizumab 62 recessive dystrophic epidermolysis bullosa 62 Glatiramer Acetate